The Latest Breaking News from Steve Reitmeister

The ever-rising healthcare costs are boosting the insurance industry in the current economic landscape. While prominent industry players Clover Health (CLOV) and Cigna Group (CI) should benefit, let us analyze which is the bigger buy.

Investing was a lot more fun during the non-stop rally between March and July. August has brought a long over due correction to the S&P 500 (SPY). The key for investors is figuring out when to buy this dip, and what are the best picks. Steve Reitmeister shares his thoughts…

The auto industry exhibits a robust outlook due to inflation coming down from its peaks and consumers’ resilient appetite for buying cars. Therefore, auto dealer stocks Asbury Automotive Group (ABG), Group 1 Automotive (GPI), and Sonic Automotive (SAH) might be watched now. Read on….

Consumers seem to be resilient in the face of macroeconomic challenges. Given stable demand, investors might consider buying consumer goods stocks Procter & Gamble (PG), Kimberly-Clark de México (KCDMY), and United-Guardian (UG), which enjoy favorable market sentiment. Read on.

The home improvement sector is projected to flourish as it rides the wave of innovation. Although Lowe's Companies (LOW) topped Wall Street's earnings estimate for the recently reported quarter, it could not meet the sales estimate. Given its mixed results, would it be wise to buy the home improvement retailer's…

The internet industry is expected to thrive due to accelerated digitalization, smart infrastructure expansion, social media popularity, and government support. Therefore, it could be wise to own industry giants Alphabet (GOOGL) and Meta Platforms (META). Keep reading.

Despite economic turbulence, the technology industry is expected to continue its impressive growth trajectory. Given the vast potential of tech, it could be wise to invest in fundamentally strong tech ETFs Vanguard Communication Services (VOX), First Trust NASDAQ Technology Dividend Index Fund (TDIV), and ETFMG Prime Cyber Security (HACK) for…

The pharmaceutical sector appears to be in a favorable position for sustained long-term expansion. While leading pharma stocks Pfizer (PFE) and Teva Pharmaceuticals (TEVA) should benefit from the industry tailwinds, let us analyze which is the better buy for Growth and Value.

Amidst market turbulence, large-cap ETFs tend to deliver stability and reliable cash flows while demonstrating less volatility. Hence, fundamentally strong large-cap ETFs Vanguard Value (VTV), Vanguard High Dividend Yield (VYM) and iShares Russell 1000 Value (IWD) might be solid additions to one’s watchlist. Continue reading.